Meta-analysis of bisoprolol/HCTZ versus twelve monotherapies

K. L. Ryschon; S. M. Mohiuddin; D. E. Hilleman

Meta-analysis of bisoprolol/HCTZ versus twelve monotherapies

K. L. Ryschon, S. M. Mohiuddin, D. E. Hilleman

Research output: Contribution to journal › Review article › peer-review

Abstract

The authors use the meta-analytic approach to compare the safety and efficacy of monotherapies versus combination therapy in the treatment of essential hypertension. Results provide clinicians and pharmacists with a wider perspective when making prescribing decisions.

Original language	English (US)
Pages (from-to)	685-695
Number of pages	11
Journal	P and T
Volume	21
Issue number	12
State	Published - 1996

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Cite this

@article{5b6010db8ad448b9a828abd966a8aecb,

title = "Meta-analysis of bisoprolol/HCTZ versus twelve monotherapies",

abstract = "The authors use the meta-analytic approach to compare the safety and efficacy of monotherapies versus combination therapy in the treatment of essential hypertension. Results provide clinicians and pharmacists with a wider perspective when making prescribing decisions.",

author = "Ryschon, {K. L.} and Mohiuddin, {S. M.} and Hilleman, {D. E.}",

year = "1996",

language = "English (US)",

volume = "21",

pages = "685--695",

journal = "P and T",

issn = "1052-1372",

publisher = "MediMedia USA Inc.",

number = "12",

}

TY - JOUR

T1 - Meta-analysis of bisoprolol/HCTZ versus twelve monotherapies

AU - Ryschon, K. L.

AU - Mohiuddin, S. M.

AU - Hilleman, D. E.

PY - 1996

Y1 - 1996

N2 - The authors use the meta-analytic approach to compare the safety and efficacy of monotherapies versus combination therapy in the treatment of essential hypertension. Results provide clinicians and pharmacists with a wider perspective when making prescribing decisions.

AB - The authors use the meta-analytic approach to compare the safety and efficacy of monotherapies versus combination therapy in the treatment of essential hypertension. Results provide clinicians and pharmacists with a wider perspective when making prescribing decisions.

UR - http://www.scopus.com/inward/record.url?scp=0030481886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030481886&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0030481886

VL - 21

SP - 685

EP - 695

JO - P and T

JF - P and T

SN - 1052-1372

IS - 12

ER -

Meta-analysis of bisoprolol/HCTZ versus twelve monotherapies

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this